{"version":"1.0","provider_name":"S&amp;C Staff Blog","provider_url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer","author_name":"Kathryn Johnson","author_url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/author\/kj57\/","title":"George Osborne trials the iKnife  - S&amp;C Staff Blog","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"3dP8R1Q5gL\"><a href=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2014\/09\/17\/george-osborne-trials-the-iknife\/\">George Osborne trials the iKnife<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2014\/09\/17\/george-osborne-trials-the-iknife\/embed\/#?secret=3dP8R1Q5gL\" width=\"600\" height=\"338\" title=\"&#8220;George Osborne trials the iKnife&#8221; &#8212; S&amp;C Staff Blog\" data-secret=\"3dP8R1Q5gL\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"George Osborne last week attended the opening of the new Waters lab facility in Wilmslow, which will now be home to\u00a0the largest site globally committed to the support and development of\u00a0mass spectrometry\u00a0systems. Walters Corporation secured a deal with Imperial in July to acquire the technology behind the surgical &#8220;iKnife&#8221; developed within Surgery and Cancers CSM [&hellip;]","thumbnail_url":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2014\/09\/Osbourne-iKnife1.jpg"}